NAUČNI KARTON UPOSLENIKA

Similar documents
NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

Fuad Džanković IME I PREZIME: DATUM I MJESTO ROĐENJA: docent AKADEMSKO ZVANJE: FAKULTET: Sveučilište Vitez Vitez MAGISTARSKI: DOKTORAT:

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

Department of Nuclear Medicine with Positron Emission Tomography

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

NAUČNI KARTON UPOSLENIKA

Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

The Concept of GOSTT

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Nuclear Medicine in Oncology

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Clinical indications for positron emission tomography

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Radionuclides in Medical Imaging. Danielle Wilson

Radiology Codes Requiring Authorization*

NAUČNI KARTON UPOSLENIKA

Hybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD

Prezime (ime roditelja) i ime Naučni stepen/zvanje. Hasanbegović (Salko) Edo. Datum rođenja Država, mjesto i općina rođenja Organizaciona jedinica

POSITRON EMISSION TOMOGRAPHY (PET)

Role of IAEA in Promoting Nuclear Medicine

Using PET/CT in Prostate Cancer

NAUČNI KARTON UPOSLENIKA

New Visions in PET: Surgical Decision Making and PET/CT

2012 CPT Radiology Codes Requiring Review Blue Cross and Blue Shield of Louisiana

Activities of the IAEA in Nuclear Medicine

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

STRADA DEGLI ALBERONI 11// TURIN ITALY. Full time employee as a freelancer contract since

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Nuclear Sciences and Medicine

05/02/ CPT Preauthorization Groupings Effective May 2, Computerized Tomography (CT) Abdomen 6. CPT Description SEGR CT01

The IAEA and Non-Communicable Diseases The Fight Against Non-Communicable Diseases

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

2017 Qualified Clinical Data Registry (QCDR) Performance Measures

Radionuclide detection of sentinel lymph node

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

declipse SPECT Imaging Probe Worldwide first registration-free ultrasound fusion with high-resolution 3D SPECT images

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

Theranostics in Nuclear Medicine

Index. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Surgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina

Isotopes in Functional Cancer Imaging

AIM 2014 CPT Radiology & Cardiac Codes Requiring Review

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

AMERICAN IMAGING MANAGEMENT

AMERICAN IMAGING MANAGEMENT

Zurich, January 19, 2018

Accuracy of Unstimulated Basal Serum Thyroglobulin Levels in Assessing the Completeness of Thyroidectomy

Regional Training Course on PET/CT in Oncology. (RER-6.035) PROGRAM

THE ROLE OF CONTEMPORARY IMAGING AND HYBRID METHODS IN THE DIAGNOSIS OF CUTANEOUS MALIGNANT MELANOMA(CMM) AND MERKEL CELL CARCINOMA (MCC)

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

PET for the Evaluation of Myocardial Viability

Preview of Presentation

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

High Tech Imaging Quick Reference Guide

PET myocard perfusion & viability Riemer Slart

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

An Introduction to PET Imaging in Oncology

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

F NaF PET/CT in the Evaluation of Skeletal Malignancy

Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast.

PUBLIC ASSESSMENT REPORT Scientific Discussion

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Cardiac Nuclear Medicine

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

Last Updated: 2/10/2017 Implementation date: 4/3/2017 Radiology & Cardiology Prior Authorization / Utilization Management Procedure List

UWE has obtained warranties from all depositors as to their title in the material deposited and as to their right to deposit such material.

Diagnostic Imaging Utilization Management and Consultation Management Programs Imaging Code Listing for Connecticut, Maine and New Hampshire

Molecular Imaging and Cancer

COLLATERAL FUNCTION IN PATIENTS WITH CORONARY OCCLUSION EVALUATED BY 201 THALLIUM SCINTIGRAPHY

PET/CT in lung cancer

Ga68 Imaging. Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:

HEALTHCARE AI DEVELOPMENT CYCLE

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

SPECT/CT Imaging of the Sentinel Lymph Node

NUCLEAR MEDICINE IN VIVO

Transcription:

1. Osnovni podaci Prezime Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA BEŠLIĆ Institut za naučnoistraživački rad i razvoj Ime NERMINA Godina rođenja 1962. Mjesto rođenja Država rođenja Zvanje Titula E mail SARAJEVO BIH Specijalista nuklearne medicine DOCENT nermina.beslic@kcus.ba Telefon/Faks 297 177 Telefon lokal 3807, 7177 Organizaciona jedinica - Disciplina UKC KLINIKA ZA NUKLEARNU MEDICINU INTERNA DISCIPLINA 2.Podaci o stečenim diplomama Godina Mjesto rada Fakultet/Univerzitet Naučna oblast Diploma 1987. SARAJEVO MEDICINSKI FAKULTET U SARAJEVU/UNSA Magisterij 2006. SARAJEVO «ZNAČAJ KORELACIJE 99mTc/MIBI SCINTIGRAFIJEBI VRIJEDNOSTI TIREOGLOBULINA U PROCJENI HLADNOG NODUSA ŠTITNE ŽLIJEZDE» MEDICINSKI FAKULTET U SARAJEVU /UNSA Doktorat 2011. SARAJEVO «KOMPARACIJA NEINVAZIVNIH METODA U DIJAGNOSTICI OBOLJENJA KORONARNIH ARTERIJA» MEDICINSKI FAKULTET U SARAJEVU/UNSA 1

Godina Mjesto Specijalizacija 2000. SARAJEVO Subspecijalizacija 3.Podaci o izborima u nastavničko/saradničko zvanje (navoditi od posljednjeg izbora u zvanje) Godina izbora zvanja Fakultet/Univerzitet Predmet Naučna oblast 2013. DOCENT MEDICINSKI FAKULTET U SARAJEVU/UNSA / 2009. VIŠI ASISTENT MEDICINSKI FAKULTET U SARAJEVU/UNSA / 2008.-2009. VIŠI ASISTENT FZS/UNSA I RADIOKEMIJA / 4. Usmjerena/kontinuirana edukacija (naziv, trajanje, godina, mjesto) Godina Mjesto Trajanje 2014. PARK HOSPITAL,ISTAMBUL, TR 15 DANA PRIMJENA PET/CTa 2013. BRIGHTON AND SUSSEX UNIVERSITYHOSPITALS, BRIGHTON, UK 2011. WILCHELMINAN SPITAL, UNIVERZITET WIEN, WIEN, AT 15 DANA 2 MJESECA IMPLEMENTACIJA PET/CT TEHNOLOGIJE MULTIMODALITI IMIDŽING, PET/CT I SPECT/CT 2007. ALGEMEINE KRANKENHAUS, UNIVERSITET WIEN, AT 2003. EUROPEAN INSTITUE OF ONCOLOGY, MILANO, IT 2001. ST.BARTOLOMEWS HOSPITAL, LONDON,UK 3 MJESECA TERAPIJA U NUKLEARNOJ MEDICINI I HIBRIDNI IDŽING: SPECT/CT I PET 1 MJESEC DETEKCIJA SENTINEL LIMFONODA KOD KARCINOMA DOJKE I MALIGNOG MELANOMA 6 MJESECI KARDIOLOGIJA,ONKOLOGIJA I TERAPIJA 2000. LEE MOFFIT CANCER CENTER, TAMPA, FLORIDA, USA 15 DANA U ONKOLOGIJI 5. Objavljeni radovi (navoditi od posljednjeg objavljenog rada) 5.1 Originalni/naučni radovi 1. Beslic N, Heber D, Lipp RW, Sonneck-Koenne C, Knoll P,Mirzaei S.Metabolic Pattern of Asymptomatic Hip- Prosthesis by 18F-FDG-Positron-Emission-Tomography.Iranian Journal of Radiology. 2014; 12(1): 11204. 2

2. Kucukalic-Selimovic E, Alagic J, Valjevac A,, Hadzovic-Dzuvo A, BegicA, Beslic N. The Value of Serum Thyreoglobulin Levels and Whole Body (I-131) Scintigraphy in the Follow-Up of the Thyroid Cancer Patients after Thyroidectomy. Coll. Antropol. 2012: 36 ( Suppl. 2) : 67 71 3. Beslic S; Beslic N; Beslic S; Sofic A; Ibralic M; Karovic J. Diagnostic imaging of traumatic pseudoaneurysm of the thoracic aorta. Radiol Oncol, 2010 ; 44(3): 158-163. 4. Al-Kaylani, H.; Britton, K. E.; Beslic, N.;Canizales, A.Can the estimation of ejection fraction during gated single photon emission computed tomography at rest add information to the Cardiac perfusion study? Nuclear Medicine Communications, 2002 ;23 (9) : 899-906 5.2 Stručni radovi 1. Balta E; Bešlić N; Bilalović N; Bešlić Š.; Šečić S; Kapetanović E, Muftić K. SLN operativna tehnika malignih tumora dojke. ACTA INFORMMED. 2006; 14 (2):83-87. 2. Bešlić N, Kučukalić-Selimović E, Šečić S. Uloga 99mTc-MIBI scintigrafije i nivoa tireoglobulina u procjeni hladnog nodusa štitne žlijezde. Medicinski žurnal 2010;16 (3):103-106. 3. Kučukalić-Selimović E; Skopljak-Beganović A; Bešlić N; Begić A; Begović-Hadžimuratović S, and Dražeta Z. Lymphoscintigraphy and radiation - Occupational Exposure during Sentinel Node Assay. BOSN J BASIC MED SCI. 2006; 6(4):42-44. 5.3 Pregledni/revijalni radovi 1. Bešlić N: Uloga detekcije sentinel limfonoda u menadžmentu pacijenata sa karcinomom dojke; Medicinski arhiv 2008; 62(4): 240-241 5.4 Prikazi slučajeva 1. Bešlić N, Kulić M, Spužić M. Perfuziona scintigrafija miokarda u procjeni perkutane transluminalne dilatacije aorto-koronarnih premoštenja. Medicinski arhiv 2007;61(2) :119-22. 5.5 Abstrakti (kongresi, simpoziji, konferencije..) 1. Bešlić N, Cerić Š, Milardović R. Somatostatin receptor scintigraphy in staging and follow up of medullary thyroid carcinoma Eighth International Congress of the Croatian Society of Nuclear Medicine and 10th Alpe Adria Nuclear Medicine Symposium, May 09-12, 2014 2. Milardović R, Bešlić N, Jurić N, Mrnjavac D, Cerić Š. FAMILY WITH GENETICALLY INHERITED FAMILIAL ADENOMATOUS POLYPOSIS (FAP) AND THYROID CANCER CASE STUDY. Naučni skup (Cito)genetika i biomedicina, Sarajevo, Maj 2014. 3. Cerić Š, Kučukalić-Selimović E, Bešlić N, Valjevac A, Begović-Hadžimuratović S. Radioactive I-131 in the treatmant of hyperthyroidsm-single institution study. Archive of Oncology 2014; Vol. 22 Suppl 1:20. 4. Beslic N, Sonneck-Koenne C, Haydari B, Knoll P, Mirzaei S. Incidental findings of periprosthetic 18-FDG deposition in asymptomatic patients with hip prosthesis. 25 TH CONGRESS OF EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE, Abstract book, Milan, Italy, October 2012. 5. Skopljak Beganović A., Bešlić N., Kučukalić-Selimović E., Tukić B. Evaluation of Personnel Radiation Dosimetry During Myocardial Perfusion Scintigraphy for Cadiology Staff. European Journal of Nuclear Medicine, Volume 37, Supplement 2/October 2010. 6. Balta E, Bešlić N,et al.sln operative technique of malignant breast tumours., 1st Interconference Breast Cancer Meeting, Abstract Book, Sarajevo, April, 2007. 3

7. Bešlić N; The role of 99mTc-MIBI scintigraphy and thyreoglobulin level in the assesement of the cold thyroid nodule, 2ND MILAN THYROID CANCER CONFERENCE, Milano, 2006. 8. Bešlić N, Kučukalić-Selimović E,et al. Accuracy of the SLN Detection in the Patients with Coutaneous malignant Melanoma., 5th International Congress of the Croatian Society of Nuclear medicine, Opatija, Maj 2005. 9. Skopljak A, Kučukalić-Selimović E,Bešlić N,et al. Safety of Sentinel Nodes Study for Surgeons, European Association of Nuclear Medicine Congress, Abstract book, Istambul, Oktobar, 2005. 10. Bešlić N; Sudžuka A, Kučukalić-Selimović E. Perfuziona tomoscintigrafija miokarda u dijagnostici i praćenju koronarnih oboljenja. UDRUŽENJE KARDIOLOGA I ANGIOLOGA BOSNE I HERCEGOVINE. XVI STRUČNI SASTANAK SA MEDJUNARODNIM UČEŠĆEM. Sarajevo. 2005. 11. Bešlić N,Sudžuka A,Kučukalić-Selimović E,et al.: Uloga perfuzione tomoscintigrafije miokarda u dijagnostici i praćenju koronarnih oboljenja, Treći kongres kardiologa i angiologa BiH, Knjiga abstrakta, Tuzla, Maj 2004. 12. Begić A; Kučukalić-Selimović E; Sudžuka A; Bešlić N, Begović-Hadžimuratović S. Myocardial perfusion scintigraphy - SPECT in patients with diabetes mellitus type-2 for detection of coronary artery disease - CAD. MED ARH. 2004; 58(2, Supl.1):74.TREĆI KONGRES KARDIOLOGA I ANGIOLOGA BIH SA MEĐUNARODNIM UČEŠĆEM, Tuzla, 27.-30.maja, 2004. 13. Milardović R, Kučukalić-Selimović E, Bešlić N, et al. Limfomi štitnjače., Prvi kongres otorinolaringologa i cervikofacijalnih hirurga FBiH,Knjiga abstrakta, Sarajevo, Oktobar 2003. 14. Bešlić N, Kucukalić-Selimović E.,et al. Tc99m-sestamibi scintgrafija i njen znacaj u evaluaciji Tc99m scintigrafski hladnoga nodusa štitne žlijezde. Prvi kongres otorinolaringologa i cervikofacijalnih hirurga FBiH,Knjiga abstrakta Sarajevo,Oktobar 2003. 15. Kučukalić-Selimović E; Durić O; Bešlagić V; Vidović Z; Džubur-Aganović M; Begović-Hadžimuratović S; Bešlić N; Begić A; Milardović R; Dražeta Z; Kapidžić A, Jurić N. Dijagnostički algoritam i menadžment pacijenata sa "sumnjivim" nodusom štitne žlijezde i evaluacija naših pacijenata sa potvrđenim karcinomom štitne žlijezde u periodu od 1993-2003- god. KONGRES OTORINOLARINGOLOGA I CERVIKOFACIJALNIH HIRURGA/KIRURGA BOSNE I HERCEGOVINE sa međunarodnim učešćem, Zbirka apstrakta (sažetaka): CD-ROM, Sarajevo, 2003. 16. Kučukalić-Selimović E; Bešlić N; Begić A; Begović-Hadžimuratović S, and Dražeta Z. Correlation of parathyroid TC-99m MIBI uptake and seum IPTH levels in patients with hyperparathyroidism. INTERNATIONAL CONGRESS OF CROATIAN SOCIATY OF NUCLEAR MEDICINE, 4th. Abstract Book; Opatija. 2002;96. 17. Kučukalić-Selimović E, Bešlić N, Gavrankapetanović F, Begović- Hadžimuratović S, Dražeta Z.: Optimisation of Tc-99m MIBI parathyroid imaging protocol in patients with primary,secondary and tertiary hyperparathyroidism. European Association of Nuclear Medicine Congress, Abstract book,vienna, August 2002. 18. Kučukalić-Selimović E, Bešlić N, Gavrankapetanović F, BegićA, Begović- Hadžimuratović S, Dražeta Z.: Correlation of parathyroid Tc-99m MIBI uptake and serum ipth levels in patients with hyperparathyroidism. European Association of Nuclear Medicine Congress, Abstract book, Vienna, August 2002. 19. Dizdarević S, Kučukalić-Selimović E, Bešlić N, Bajgorić M, Durić O, Selak I,Dražeta Z, Begović-Hadžimuratović S.: The diagnostic value of cold thyroid nodules 99m Tc-MIBI scintigraphy in the selection of patients for surgery.eur J Nuc Med 2000;27(8): 1150 (Abstract), France, September, 2000. 6. Objavljene publikacije (knjige, udžbenici, monografije, vodiči, praktikumi) publikacije Poglavlje : Nuklearno-medicinske pretrage pacijenata sa stabilnom anginom pektoris U: Kulić M. Stabilna angina pektoris Autor/autori Bešlić N. Izdavač Vrsta publikacije Institut za nastavnoistraživački rad i razvoj, KCUS. knjiga 4

Godina izdavanja 2010. 7. Ostvareni projekti (navoditi od posljednjeg ostvarenog projekta) 8. Mentorstvo (magisteriji, doktorati) 9. Radionice, tečajevi ESNM advanced Learning Course on PET/CT in Oncology Datum 2014. EANM Current trends in oncology: From diagnosis to therapy, Novi Sad, Serbia Datum 2011. Onkološki institut Vojvodine Prvi kurs iz Osnovnih principa Evidenece based medicine, Sarajevo Datum 2009. Medicinski fakultet, Sarajevo Learning Course on PET and PET-CT in Oncology, Beč, Austi, Datum 2008. EANM Nacionalni trening kurs iz nuklearne kardio-respiratorne dijagnostike i receptor imidžinga,sarajevo, BIH Datum 2008. KCUS u saradnji sa IAEA Nacionalni trening kurs, Pedijatrijska nuklearna medicina, Banja Luka, BIH 5

Datum 2007. KC Banja Luka u saradnji sa IAEA Regionalni trening kurs o ulozi nuklearne medicine u urgentnim stanjima, Guadremagia, Malta, Datum 2002. IAEA Evidence Based management of Breast cancer, Sarajevo, BIH, Datum 2001. European School of Oncology Regionalni trening kurs o aplikaciji radionuklearnih tehnika u nuklearnoj onkologiji, Ljubljana, Slovenia Datum 1999. IAEA Regionalni trening kurs iz opšte nuklearne medicine, Budimpesta, Mađarska Datum 1998. IAEA 10. Poznavanje stranog jezika (EU CEFR) Jezik A1 A2 ( osnovno služenje jezikom) B1 B2 (samostalno služenje jezikom) C1 C2 (kompetentno služenje jezikom) njemački engleski 6

11. Saradnja sa institucijama relevantnim za stručnu ili naučnu oblast International Atomic Energy Agency - IAEA Evropsko udruženje nuklearne medicine - EANM 12. Predavanja po pozivu Tema Datum Mjesto Institucija 1. I131 Metajodobenzilguanidin terapija u pedijatrijskoj onkologiji Maj, 2007. Banja Luka Nacionalni trening kurs o Pedijatrisjkoj nuklearnoj medicini. 2. Detekcija i menadžment sentinel limfonoda kod kožnog maignog melanoma Novembar, 2008. Sarajevo Nacionalni trening kurs o Kardiorespiratornoj dijagnostici i receptor imidžingu. 3. Value of SLN biopsy in patients with cutaneous melanoma. Maj, 2013. Beograd 2. BalkanskI kongeres nuklearne medicine-bcnm 13. Recenzije i uredništvo u domaćim i međunarodnim knjigama i časopisima(upisati) 14. Priznanja i pohvale Svojim potpisom odgovorno potvrđujem da su svi podaci koji su objavljeni u Naučnom kartonu pod mojim imenom u cijelosti tačni i provjerljivi Datum Potpis 17.02.2015. Doc.dr Nermina Bešlić 7